NASDAQ: CMPS

COMPASS Pathways plc

Healthcare | Medical - Care Facilities

Market prices for CMPS are shown to signed-in users (sign in). This public page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

COMPASS Pathways plc (NASDAQ: CMPS) is a healthcare facilities operator. Figures from SEC EDGAR; updated 2026-10-20 09:57 UTC.

What COMPASS Pathways plc does

Compass Pathways is a biotechnology company developing COMP360, a proprietary psilocybin formulation designed to treat serious mental health conditions. The company's initial focus is treatment-resistant depression, for which COMP360 received Breakthrough Therapy designation from the FDA. The company completed Phase 2b clinical trials showing that COMP360 demonstrated statistically significant reductions in depressive symptoms and has advanced to Phase 3 pivotal trials, with both trials achieving their primary endpoints.

Summarized from COMPASS Pathways plc’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Charts

Charts are in the appInteractive charts for CMPS are available in Oxford Ledge.
Open CMPS in Oxford Ledge →

SEC Filings

SEC EDGAR ↗

Recent Insider Activity (last 90 days)

Source: SEC EDGAR · Filed 2026-08-05

2026-08-05Chief Executive OfficerTax withholding-5,962$67.1K
2026-05-29DirectorShare Option (Right to Buy)Award21,110—
2026-05-29DirectorShare Option (Right to Buy)Award21,110—

Top Institutional Holders (latest 13F)

Source: SEC EDGAR · As of 2026-Q2

Deep Track Capital, LP12,161,496$172.09M0.0%
RTW INVESTMENTS, LP10,700,974$151.42M+0.7%
BIT Capital GmbH6,348,797$89.84M+81.8%

View QoQ ownership changes →Full institutional ownership →

Recent 8-K Events (parsed from SEC filings)All events →

Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

2025-04-16AuditorChanges in registrant's certifying accountantPwCEstimatedSEC 8-K →
2023-12-07Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →
2023-10-26Exec ChangeDeparture of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officersEstimatedSEC 8-K →

Company news

View all →

COMPASS Pathways (CMPS) Stock May Trade At A Premium After Positive Phase 3 Results
Yahoo2026-10-18POS
Compass Pathways CEO: Psychedelics company will ‘go slow before we go fast’
STAT News2026-10-15
Compass Pathways Joins Forces with Leading Mental Health Organizations to Mark First-Ever U.S. Treatment-Resistant Depression (TRD) Awareness Day
Yahoo2026-10-14
Cathie Wood-Led Ark Invest Sells AMD, SPCX, GOOG Stocks — But Loads Up On CMPS, NTLA, CRSP And Other Healthcare Firms
Yahoo2026-10-10
Compass Pathways Reports Q2 2026 Results: Full Earnings Call Transcript
Benzinga2026-10-08

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for CMPS and 5,000+ tickers.

Create a free account — keep CMPS

For your agent

GET /api/data?ticker=CMPS

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt